CPRX
Catalyst Pharmaceuticals Inc
$21.12
Earnings Summary
Revenue | $126.42Mn |
Net Profits | $43.88Mn |
Net Profit Margins | 34.71% |
Highlights
Catalyst Pharmaceuticals Inc’s revenue jumped 23.11% since last year same period to $126.42Mn in the Q3 2024. On a quarterly growth basis, Catalyst Pharmaceuticals Inc has generated 3.03% jump in its revenue since last 3-months.
Catalyst Pharmaceuticals Inc’s net profit jumped 242.65% since last year same period to $43.88Mn in the Q3 2024. On a quarterly growth basis, Catalyst Pharmaceuticals Inc has generated 7.57% jump in its net profits since last 3-months.
Catalyst Pharmaceuticals Inc’s net profit margin jumped 215.87% since last year same period to 34.71% in the Q3 2024. On a quarterly growth basis, Catalyst Pharmaceuticals Inc has generated 4.41% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Catalyst Pharmaceuticals Inc post its latest quarter earnings
EPS Estimate Current Quarter | 0.3 |
EPS Estimate Current Year | 0.3 |
Highlights
Catalyst Pharmaceuticals Inc’s earning per share (EPS) estimates for the current quarter stand at 0.3 - a 15.38% jump from last quarter’s estimates.
Catalyst Pharmaceuticals Inc’s earning per share (EPS) estimates for the current year stand at 0.3.
Key Ratios
Key ratios of the Catalyst Pharmaceuticals Inc post its Q3 2024 earnings
Earning Per Share (EPS) | 0.35 |
Highlights
Catalyst Pharmaceuticals Inc’s earning per share (EPS) jumped 220.69% since last year same period to 0.35 in the Q3 2024. This indicates that the Catalyst Pharmaceuticals Inc has generated 220.69% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2024-11-06 | 0.3 | 0.35 | 16.67% |
2024-05-08 | 0.17 | 0.19 | 11.76% |
2024-08-07 | 0.26 | 0.33 | 26.92% |
₹0 US Stocks a/c Opening Fee